marketcaparena
Search

    SGP

    SpyGlass Pharma, Inc.

    Company overview

    Market capitalization
    $868.98M
    Employees
    65
    Latest publication
    2026-09-29
    About SpyGlass Pharma, Inc.

    SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was incorporated in 2019 and is based in Aliso Viejo, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
    Total Revenue0USD0USD0USD0USD
    Cost Of Revenue318,000USD216,726USD——
    Gross Profit-318,000USD-216,726USD——
    Research Development8,241,000USD7,705,244USD6,052,000USD5,739,543USD
    Selling General Administrative6,867,000USD5,922,467USD1,371,000USD2,014,359USD
    Total Operating Expenses15,091,000USD13,410,985USD7,423,000USD7,753,902USD
    Operating Income-15,409,000USD-13,627,711USD-7,423,000USD-7,753,902USD
    Interest Income1,591,000USD1,072,472USD126,000USD207,181USD
    Net Interest Income1,591,000USD1,072,472USD126,000USD207,181USD
    Income Before Tax-13,818,000USD-12,555,228USD-8,823,000USD-8,399,266USD
    Tax Provision0USD0USD0USD0USD
    Net Income-13,818,000USD-12,555,228USD-8,823,000USD-8,399,266USD
    Net Income From Continuing Ops-13,818,000USD-12,555,228USD-8,823,000USD-8,399,266USD
    Ebit-15,409,000USD-13,627,711USD——
    Ebitda-15,091,000USD-13,410,985USD——
    Depreciation And Amortization318,000USD216,726USD——
    Reconciled Depreciation318,000USD216,726USD124,000USD107,904USD
    Total Other Income Expense Net1,591,000USD1,072,483USD-1,526,000USD-852,545USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Total Revenue0USD0USD0USD
    Cost Of Revenue612,000USD——
    Gross Profit-612,000USD——
    Research Development28,640,000USD19,984,000USD9,959,606USD
    Selling General Administrative12,197,000USD7,080,000USD4,270,759USD
    Total Operating Expenses40,837,000USD27,064,000USD14,230,365USD
    Operating Income-41,449,000USD-27,064,000USD-14,230,365USD
    Interest Income3,106,000USD1,317,000USD911,375USD
    Net Interest Income3,106,000USD1,317,000USD911,375USD
    Income Before Tax-39,869,000USD-29,164,000USD-13,318,990USD
    Tax Provision0USD0USD0USD
    Net Income-39,869,000USD-29,164,000USD-13,318,990USD
    Net Income From Continuing Ops-39,869,000USD-29,164,000USD-13,318,990USD
    Ebit-41,449,000USD——
    Ebitda-40,837,000USD——
    Depreciation And Amortization612,000USD——
    Reconciled Depreciation612,000USD271,000USD122,668USD
    Total Other Income Expense Net1,580,000USD-3,417,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20242024-12-31 · USD
    Total Assets258,386,000USD115,866,000USD127,012,143USD23,318,000USD
    Other Current Assets1,707,000USD901,000USD1,239,435USD229,265USD
    Total Liab8,273,999USD214,703,000USD214,236,927USD83,792,000USD
    Total Stockholder Equity250,112,000USD-98,837,000USD-87,224,784USD-60,474,000USD
    Other Current Liab3,153,000USD5,888,000USD4,451,200USD4,089,000USD
    Capital Stock0USD0USD41USD0USD
    Retained Earnings-118,548,000USD-104,730,000USD-92,175,261USD-64,861,000USD
    Cash238,902,000USD96,358,000USD106,006,749USD16,268,000USD
    Cash And Short Term Investments251,002,000USD107,436,000USD118,038,884USD—
    Total Current Assets253,362,000USD108,768,000USD119,696,326USD17,406,000USD
    Total Current Liabilities6,667,000USD8,584,000USD6,610,381USD7,791,000USD
    Net Debt-237,295,000USD-94,776,000USD-102,438,308USD—
    Short Long Term Debt Total1,607,000USD1,582,000USD3,568,441USD—
    Short Term Investments12,100,000USD11,078,000USD12,032,135USD0USD
    Net Receivables653,000USD431,000USD418,007USD—
    Accounts Payable3,514,000USD2,696,000USD1,679,743USD1,978,000USD
    Property Plant Equipment Net4,235,000USD3,891,000USD5,125,151USD5,459,000USD
    Property Plant Equipment Gross5,667,000USD5,005,000USD6,058,898USD6,002,000USD
    Common Stock Shares Outstanding19,927,848shares33,426,557shares31,911,164shares31,911,164shares
    Non Current Assets Total5,024,000USD7,098,000USD7,315,817USD5,912,000USD
    Non Current Liabilities Total1,606,999USD206,119,000USD207,626,546USD76,001,000USD
    Non Currrent Assets Other789,000USD3,207,000USD2,190,666USD453,000USD
    Net Working Capital246,695,000USD100,184,000USD113,085,945USD9,615,000USD
    Unclassified Non Current Liabilities1,606,999USD206,119,000USD207,626,546USD76,001,000USD
    Unclassified Equity368,660,000USD5,893,000USD4,950,395USD4,387,000USD
    Common Stock——41USD—
    Short Term Debt——479,438USD—
    Unclassified Current Liabilities———1,724,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Total Assets115,866,000USD23,318,000USD41,149,466USD
    Other Current Assets901,000USD229,265USD—
    Total Liab214,703,000USD83,792,000USD74,134,984USD
    Total Stockholder Equity-98,837,000USD-60,474,000USD-32,985,518USD
    Other Current Liab5,888,000USD4,089,000USD340,496USD
    Capital Stock0USD0USD16USD
    Retained Earnings-104,730,000USD-64,861,000USD-35,697,581USD
    Cash96,358,000USD16,268,000USD15,848,682USD
    Cash And Short Term Investments107,436,000USD——
    Total Current Assets108,768,000USD17,406,000USD40,614,859USD
    Total Current Liabilities8,584,000USD7,791,000USD1,588,656USD
    Net Debt-94,776,000USD——
    Short Long Term Debt Total1,582,000USD——
    Short Term Investments11,078,000USD0USD24,467,793USD
    Net Receivables431,000USD——
    Accounts Payable2,696,000USD1,978,000USD639,161USD
    Property Plant Equipment Net3,891,000USD5,459,000USD448,491USD
    Property Plant Equipment Gross5,005,000USD6,002,000USD719,691USD
    Common Stock Shares Outstanding33,426,557shares31,911,164shares31,911,164shares
    Non Current Assets Total7,098,000USD5,912,000USD534,607USD
    Non Current Liabilities Total206,119,000USD76,001,000USD72,546,328USD
    Non Currrent Assets Other3,207,000USD453,000USD86,116USD
    Net Working Capital100,184,000USD9,615,000USD39,026,203USD
    Unclassified Non Current Liabilities206,119,000USD76,001,000USD72,546,328USD
    Unclassified Equity5,893,000USD4,387,000USD2,712,047USD
    Unclassified Current Liabilities—1,724,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
    Net Income-13,818,000USD-12,555,228USD-8,823,000USD-8,399,266USD
    Depreciation318,000USD216,726USD124,000USD107,904USD
    Stock Based Compensation1,675,000USD922,246USD345,000USD407,620USD
    Other Non Cash Items1,707,000USD-478,868USD99,000USD128,708USD
    Change To Account Receivables-222,000USD-12,686USD——
    Change In Working Capital-1,751,000USD2,560,948USD-1,472,000USD652,929USD
    Total Cash From Operating Activities-13,544,000USD-9,334,176USD-8,201,000USD-6,249,560USD
    Capital Expenditures-676,000USD-420,492USD-164,000USD-438,974USD
    Free Cash Flow-14,220,000USD-9,754,668USD-8,365,000USD-6,688,534USD
    Investments-991,000USD995,190USD0USD4,481,323USD
    Total Cashflows From Investing Activities-1,667,000USD574,698USD——
    Total Cash From Financing Activities157,755,000USD-889,643USD50,096,000USD142,566USD
    Issuance Of Capital Stock160,425,000USD279USD50,010,000USD0USD
    Change In Cash142,544,000USD-9,648,749USD41,731,000USD-2,064,645USD
    Begin Period Cash Flow96,358,000USD106,006,749USD16,268,000USD18,332,273USD
    End Period Cash Flow238,902,000USD96,358,000USD57,999,000USD16,267,628USD
    Unclassified Operating Cash Flow-1,675,000USD—1,526,000USD—
    Unclassified Financing Cash Flow-2,670,000USD———
    Sale Purchase Of Stock—0USD——
    Other Cashflows From Financing Activities—-909,489USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Net Income-39,869,000USD-29,164,000USD-13,318,990USD
    Depreciation612,000USD271,000USD122,668USD
    Stock Based Compensation2,786,000USD1,490,000USD874,196USD
    Other Non Cash Items1,322,000USD621,000USD-67,904USD
    Change To Account Receivables-8,000USD——
    Change In Working Capital2,448,000USD1,338,000USD112,297USD
    Total Cash From Operating Activities-32,701,000USD-22,027,000USD-12,277,733USD
    Capital Expenditures-789,000USD-1,991,000USD-216,542USD
    Free Cash Flow-33,490,000USD-24,018,000USD-12,494,275USD
    Investments-11,005,000USD24,252,000USD-20,269,686USD
    Total Cashflows From Investing Activities-11,794,000USD——
    Total Cash From Financing Activities124,585,000USD185,000USD39,769,970USD
    Sale Purchase Of Stock-1,450,000USD0USD—
    Issuance Of Capital Stock127,336,000USD0USD40,009,994USD
    Change In Cash80,090,000USD419,000USD7,006,009USD
    Begin Period Cash Flow16,268,000USD15,849,000USD8,842,673USD
    End Period Cash Flow96,358,000USD16,268,000USD15,848,682USD
    Other Cashflows From Financing Activities125,865,000USD——
    Unclassified Operating Cash Flow—3,417,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.